The pathogenesis of fibrostenotic disease is multifactorial involving the activation of mesenchymal cells by cytokines, growth factors, and other mediators released by immune cells, epithelial cells, and mesenchymal cells.  Numerous growth factors cytokines and other mediators also contribute to development of fibrosis in the susceptible patient. 
THERM